147 related articles for article (PubMed ID: 38289775)
1. Primary Systemic Amyloidosis: A Case Report.
Oli SS; Jha A; Karki A; Sapkota S; Adhikari L
JNMA J Nepal Med Assoc; 2023 Oct; 61(266):822-824. PubMed ID: 38289775
[TBL] [Abstract][Full Text] [Related]
2. Axillary Lymphadenopathy as an Initial Presentation of Systemic Amyloidosis: A Case Report and Literature Review.
Kumar S; Grell GR; Joseph G; Wang JC
J Investig Med High Impact Case Rep; 2022; 10():23247096221133191. PubMed ID: 36300416
[TBL] [Abstract][Full Text] [Related]
3. Systemic light chain amyloidosis myopathy responsive to daratumumab monotherapy.
Chitimus DM; Berling E; Garderet L; Venturelli N; Malfatti E; Authier FJ; Nicolas G; Laforêt P; Lefeuvre C
Eur J Neurol; 2023 Mar; 30(3):745-748. PubMed ID: 36403110
[TBL] [Abstract][Full Text] [Related]
4. Gastroduodenal Involvement in AL Amyloidosis: Case Report and Literature Review.
Ramachandran R; Grantham T; Isaac-Coss G; Etienne D; Reddy M
J Investig Med High Impact Case Rep; 2024; 12():23247096241237759. PubMed ID: 38462925
[TBL] [Abstract][Full Text] [Related]
5. AL-Kappa Primary Amyloidosis with Apolipoprotein A-IV Deposition.
Ishimitsu A; Tojo A; Hirao J; Yokoyama S; Ohira T; Murayama Y; Ishimitsu T; Kang D; Honda K; Ehara T; Ishida K; Ueda Y
Intern Med; 2022; 61(6):871-876. PubMed ID: 35296622
[TBL] [Abstract][Full Text] [Related]
6. Daratumumab: A Review in Newly Diagnosed Systemic Light Chain Amyloidosis.
Blair HA
Drugs; 2022 Apr; 82(6):683-690. PubMed ID: 35416593
[TBL] [Abstract][Full Text] [Related]
7. Hepatic veno-occlusive disease may be a rare characteristic of hepatic involvement in systemic amyloidosis: case report and literature review.
Zhu TY; Zhou GH; Chen XH; Teng XD; Sun JH
J Int Med Res; 2020 Feb; 48(2):300060520904857. PubMed ID: 32090649
[TBL] [Abstract][Full Text] [Related]
8. Multiorgan involvement by amyloid light chain amyloidosis.
Li G; Han D; Wei S; Wang H; Chen L
J Int Med Res; 2019 Apr; 47(4):1778-1786. PubMed ID: 30803274
[TBL] [Abstract][Full Text] [Related]
9. Successful Treatment of Systemic Light Chain Amyloidosis with Liver Involvement using Low-Frequency Daratumumab: A Case Report.
Meng X; He J; Cheng F; Yan H; Zhu C; Guo X; Li Y; Cai Z; He D
Am J Case Rep; 2024 Jan; 25():e942534. PubMed ID: 38229422
[TBL] [Abstract][Full Text] [Related]
10. [Treatment strategy for immunoglobulin light chain amyloidosis].
Fuchida SI
Rinsho Ketsueki; 2021; 62(8):1160-1166. PubMed ID: 34497203
[TBL] [Abstract][Full Text] [Related]
11. Renal failure due to primary amyloidosis: a case report and literature review.
de Mello RA; Marques Santos DS; Freitas-Silva MP; Andrade JA
Sao Paulo Med J; 2011 May; 129(3):176-80. PubMed ID: 21755253
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin Light Chain Amyloidosis Presenting as Inferior Vena Cava Thrombosis.
Axentiev A; Rozik M; Slama E; Setya V
Am Surg; 2023 Jun; 89(6):2788-2790. PubMed ID: 34743583
[TBL] [Abstract][Full Text] [Related]
13. Effect of the Presence of t(11;14) for Patients With AL Amyloidosis Treated With Bortezomib-Containing Regimens: Experience From the Amyloidosis Program of Calgary.
Lewis E; McCulloch S; Mahe E; Bahlis N; Neri P; Tay J; Duggan P; Jimenez-Zepeda VH
Clin Lymphoma Myeloma Leuk; 2023 Oct; 23(10):e331-e334. PubMed ID: 37532664
[No Abstract] [Full Text] [Related]
14. Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis.
Brennan X; Withers B; Jabbour A; Milliken S; Kotlyar E; Fay K; Ma D; Muthiah K; Hamad N; Dodds A; Bart N; Keogh A; Hayward C; Macdonald P; Moore J
Intern Med J; 2022 Oct; 52(10):1826-1830. PubMed ID: 36266066
[TBL] [Abstract][Full Text] [Related]
15. Complete remission of both immunoglobulin light chain amyloidosis and psoriasis after autologous hematopoietic stem cell transplantation: A case report.
Chen W; Ren G; Zuo K; Huang X
Medicine (Baltimore); 2018 Dec; 97(50):e13589. PubMed ID: 30558027
[TBL] [Abstract][Full Text] [Related]
16. Primary systemic amyloidosis with skin and cardiac involvement: a case report.
Trajber Horvat A; Trčko K; Jurčić V; Marko PB
Acta Dermatovenerol Alp Pannonica Adriat; 2018 Mar; 27(1):45-47. PubMed ID: 29589647
[TBL] [Abstract][Full Text] [Related]
17. Progressive chorioretinal involvement in a patient with light-chain (AL) amyloidosis: a case report.
Augstburger E; Sahel JA; Audo I
BMC Ophthalmol; 2020 Feb; 20(1):59. PubMed ID: 32085748
[TBL] [Abstract][Full Text] [Related]
18. Daratumumab, lenalidomide and dexamethasone in newly diagnosed systemic light chain amyloidosis patients associated with multiple myeloma.
Kawano Y; Hata H; Takashio S; Tsujita K; Ueda M; Matsuoka M
Br J Haematol; 2022 Aug; 198(3):e38-e41. PubMed ID: 35524546
[No Abstract] [Full Text] [Related]
19. A nationwide prospective registry of bortezomib-based therapy in light chain (AL) amyloidosis.
Palladini G; Celant S; Milani P; Summa V; Affronti G; Olimpieri PP; Petraglia S; Foli A; Nuvolone M; Merlini G; Russo P;
Leuk Lymphoma; 2022 Jan; 63(1):205-211. PubMed ID: 34448427
[TBL] [Abstract][Full Text] [Related]
20. Macroglossia Associated With Primary Systemic Amyloidosis - Case Report With Unusual Clinical Presentation.
Muniyan S; Nair Sreela LS; Mathew P; Prasad T; Nair AS; Jose M
J Ayub Med Coll Abbottabad; 2022; 34(1):197-199. PubMed ID: 35466653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
